Utah Retirement Systems Exelixis, Inc. Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Exelixis, Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 47,363 shares of EXEL stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,363

Previous 47,363 -0.0%

Holding current value

$1.63 Million

Previous $1.06 Million 15.51%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $126,108 - $147,126	-6,200 Reduced 11.58%	47,363 $1.06 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $30,255 - $35,895	-1,500 Reduced 2.72%	53,563 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $1,925 - $2,413	-100 Reduced 0.18%	55,063 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $7,616 - $9,096	400 Added 0.73%	55,163 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $21,804 - $24,576	-1,200 Reduced 2.14%	54,763 $1.05 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $6,520 - $7,764	400 Added 0.72%	55,963 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $6,272 - $8,908	400 Added 0.73%	55,563 $871,000
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $17,030 - $22,670	-1,000 Reduced 1.78%	55,163 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $3,168 - $4,376	200 Added 0.36%	56,163 $1.03 Million
Q3 2021 Nov 16, 2021	SELL	$16.3 - $21.14 $50,530 - $65,534	-3,100 Reduced 5.25%	55,963 $1.18 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $1,795 - $2,556	100 Added 0.17%	59,063 $1.08 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $51,325 - $63,050	-2,500 Reduced 4.07%	58,963 $1.33 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $58,848 - $79,360	3,200 Added 5.49%	61,463 $1.23 Million
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $8,268 - $10,776	400 Added 0.69%	58,263 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $16,460 - $27,420	1,000 Added 1.76%	57,863 $1.37 Million
Q4 2019 Feb 12, 2020	BUY	$15.15 - $18.89 $3,030 - $3,778	200 Added 0.35%	56,863 $1 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $8,840 - $11,325	500 Added 0.89%	56,663 $1 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $17,112 - $22,374	904 Added 1.64%	56,163 $1.2 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $12,014 - $15,177	613 Added 1.12%	55,259 $1.32 Million
Q4 2018 Feb 08, 2019	BUY	$13.65 - $21.8 $1,365 - $2,180	100 Added 0.18%	54,646 $1.08 Million
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $4,761 - $6,720	300 Added 0.55%	54,546 $967,000
Q2 2018 Aug 10, 2018	SELL	$18.56 - $22.45 $1,855 - $2,245	-100 Reduced 0.18%	54,246 $1.17 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $15,504 - $22,323	700 Added 1.3%	54,346 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $16,961 - $21,651	700 Added 1.32%	53,646 $1.63 Million
Q3 2017 Nov 13, 2017	BUY	$23.35 - $29.24 $1.24 Million - $1.55 Million	52,946	52,946 $1.28 Million

Others Institutions Holding EXEL

# of Institutions

498

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Exelixis, Inc. Transaction History